NDC 63323-562 – Bivalirudin

Bivalirudin 250 mg/1 · Injection, Powder, Lyophilized, For Solution · Intravenous

Human Prescription Drug

Product NDC63323-562

Product details

Brand name
Bivalirudin
Generic name
Bivalirudin
Labeler
Fresenius Kabi USA, LLC
Dosage form
Injection, Powder, Lyophilized, For Solution
Route
Intravenous
Marketing category
ANDA · ANDA090189
Marketed since
October 30, 2017
Listing expires
December 31, 2026
Pharmacologic class
Anti-coagulant; Direct Thrombin Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Bivalirudin →

Package NDC codes (2)

Package NDCDescriptionSince
63323-562-1010 VIAL, SINGLE-USE in 1 CARTON (63323-562-10) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USEOct 28, 2016
63323-562-1510 VIAL, SINGLE-USE in 1 CARTON (63323-562-15) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE (63323-562-41)Oct 30, 2017

Other Bivalirudin products